25 XP   0   0   10

Celularity Inc
Buy, Hold or Sell?

Let's analyse Celularity together

PenkeI guess you are interested in Celularity Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Celularity Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Celularity Inc

I send you an email if I find something interesting about Celularity Inc.

Quick analysis of Celularity (30 sec.)










What can you expect buying and holding a share of Celularity? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$1.39
Expected worth in 1 year
$-6.35
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$-7.74
Return On Investment
-252.1%

For what price can you sell your share?

Current Price per Share
$3.07
Expected price per share
$1.69 - $4.7
How sure are you?
50%

1. Valuation of Celularity (5 min.)




Live pricePrice per Share (EOD)

$3.07

Intrinsic Value Per Share

$-20.55 - $-24.05

Total Value Per Share

$-19.16 - $-22.66

2. Growth of Celularity (5 min.)




Is Celularity growing?

Current yearPrevious yearGrowGrow %
How rich?$30.2m$150.7m-$67.1m-80.3%

How much money is Celularity making?

Current yearPrevious yearGrowGrow %
Making money-$74.9m$3.5m-$78.4m-104.7%
Net Profit Margin-2,054.5%228.8%--

How much money comes from the company's main activities?

3. Financial Health of Celularity (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#529 / 1010

Most Revenue
#385 / 1010

Most Profit
#939 / 1010

Most Efficient
#849 / 1010

What can you expect buying and holding a share of Celularity? (5 min.)

Welcome investor! Celularity's management wants to use your money to grow the business. In return you get a share of Celularity.

What can you expect buying and holding a share of Celularity?

First you should know what it really means to hold a share of Celularity. And how you can make/lose money.

Speculation

The Price per Share of Celularity is $3.07. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Celularity.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Celularity, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.39. Based on the TTM, the Book Value Change Per Share is $-1.94 per quarter. Based on the YOY, the Book Value Change Per Share is $2.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Celularity.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-4.31-140.4%-2.48-80.9%0.258.0%-0.41-13.2%-0.41-13.2%
Usd Book Value Change Per Share1.2340.1%-1.94-63.0%2.0867.8%0.072.3%0.072.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share1.2340.1%-1.93-63.0%2.0867.8%0.072.3%0.072.3%
Usd Price Per Share0.25-0.41-3.93-5.56-5.56-
Price to Earnings Ratio-0.01--0.06-4.14--527.00--527.00-
Price-to-Total Gains Ratio0.20--0.12--11.04--1,852.11--1,852.11-
Price to Book Ratio0.18-0.45-4.58-3.23-3.23-
Price-to-Total Gains Ratio0.20--0.12--11.04--1,852.11--1,852.11-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.07
Number of shares325
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-1.940.07
Usd Total Gains Per Share-1.930.07
Gains per Quarter (325 shares)-628.7622.63
Gains per Year (325 shares)-2,515.0390.51
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11-2516-252509081
23-5033-50401181172
34-7549-75551271263
45-10065-100701361354
56-12582-125851451445
68-15098-151002542536
79-17614-176152632627
810-20130-201302722718
912-22647-226452812809
1013-25163-251603903900

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%5.07.00.041.7%10.010.00.050.0%10.010.00.050.0%10.010.00.050.0%
Book Value Change Per Share1.03.00.025.0%7.05.00.058.3%12.08.00.060.0%12.08.00.060.0%12.08.00.060.0%
Dividend per Share2.00.02.050.0%2.00.010.016.7%2.00.018.010.0%2.00.018.010.0%2.00.018.010.0%
Total Gains per Share1.03.00.025.0%7.05.00.058.3%12.08.00.060.0%12.08.00.060.0%12.08.00.060.0%

Fundamentals of Celularity

About Celularity Inc

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, an allogeneic CAR-T cell for the treatment of non-Hodkin's lymphoma (NHL) and mantle cell lymphoma (MCL); CYNK-001, an allogeneic unmodified natural killer cell that is in Phase I/II clinical trial for the treatment of acute myeloid leukemia (AML); and APPL-001, a genetically modified placental-derived mesenchymal-like adherent stromal cell for the treatment of Crohn's disease. It is also developing CYCART-201 for the treatment of NHL and MCL, and human epidermal growth factor receptor 2 positive cancers; CYNK-301, a next generation chimeric antigen receptor-natural killer (CAR-NK) for treating relapse refractory AML; CYNK-302, a CAR-NK to treat non-small cell lung cancer; and pExo-001, a human postpartum placenta derived exosome product for the treatment of osteoarthritis. It also produces, sells, and licenses products that are used in surgical and wound care markets, such as Biovance, Biovance 3L, Interfyl, and Centaflex; and collects and stores stem cells from umbilical cords and placentas under the LifebankUSA brand. The company has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. The company was founded in 1998 and is based in Florham Park, New Jersey.

Fundamental data was last updated by Penke on 2024-04-11 03:53:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Celularity Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Celularity earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Celularity to the Biotechnology industry mean.
  • A Net Profit Margin of -2,479.6% means that $-24.80 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Celularity Inc:

  • The MRQ is -2,479.6%. The company is making a huge loss. -2
  • The TTM is -2,054.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-2,479.6%TTM-2,054.5%-425.1%
TTM-2,054.5%YOY228.8%-2,283.3%
TTM-2,054.5%5Y-662.9%-1,391.6%
5Y-662.9%10Y-662.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,479.6%-207.2%-2,272.4%
TTM-2,054.5%-216.8%-1,837.7%
YOY228.8%-282.3%+511.1%
5Y-662.9%-436.8%-226.1%
10Y-662.9%-597.3%-65.6%
1.1.2. Return on Assets

Shows how efficient Celularity is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Celularity to the Biotechnology industry mean.
  • -59.7% Return on Assets means that Celularity generated $-0.60 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Celularity Inc:

  • The MRQ is -59.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -39.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-59.7%TTM-39.1%-20.6%
TTM-39.1%YOY1.0%-40.1%
TTM-39.1%5Y-11.9%-27.2%
5Y-11.9%10Y-11.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-59.7%-13.3%-46.4%
TTM-39.1%-12.8%-26.3%
YOY1.0%-11.6%+12.6%
5Y-11.9%-13.8%+1.9%
10Y-11.9%-15.6%+3.7%
1.1.3. Return on Equity

Shows how efficient Celularity is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Celularity to the Biotechnology industry mean.
  • -310.4% Return on Equity means Celularity generated $-3.10 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Celularity Inc:

  • The MRQ is -310.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -175.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-310.4%TTM-175.6%-134.8%
TTM-175.6%YOY-5.7%-169.9%
TTM-175.6%5Y-40.5%-135.1%
5Y-40.5%10Y-40.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-310.4%-16.9%-293.5%
TTM-175.6%-16.1%-159.5%
YOY-5.7%-14.9%+9.2%
5Y-40.5%-19.3%-21.2%
10Y-40.5%-20.1%-20.4%

1.2. Operating Efficiency of Celularity Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Celularity is operating .

  • Measures how much profit Celularity makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Celularity to the Biotechnology industry mean.
  • An Operating Margin of -406.2% means the company generated $-4.06  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Celularity Inc:

  • The MRQ is -406.2%. The company is operating very inefficient. -2
  • The TTM is -714.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-406.2%TTM-714.3%+308.1%
TTM-714.3%YOY-353.7%-360.5%
TTM-714.3%5Y-419.7%-294.5%
5Y-419.7%10Y-419.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-406.2%-298.0%-108.2%
TTM-714.3%-238.5%-475.8%
YOY-353.7%-288.4%-65.3%
5Y-419.7%-486.2%+66.5%
10Y-419.7%-628.4%+208.7%
1.2.2. Operating Ratio

Measures how efficient Celularity is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 5.37 means that the operating costs are $5.37 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Celularity Inc:

  • The MRQ is 5.369. The company is inefficient in keeping operating costs low. -1
  • The TTM is 8.509. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5.369TTM8.509-3.140
TTM8.509YOY9.528-1.018
TTM8.5095Y6.261+2.248
5Y6.26110Y6.2610.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.3693.235+2.134
TTM8.5093.310+5.199
YOY9.5283.838+5.690
5Y6.2615.679+0.582
10Y6.2617.823-1.562

1.3. Liquidity of Celularity Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Celularity is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.19 means the company has $0.19 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Celularity Inc:

  • The MRQ is 0.195. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.261. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.195TTM0.261-0.066
TTM0.261YOY1.663-1.402
TTM0.2615Y2.635-2.374
5Y2.63510Y2.6350.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1953.863-3.668
TTM0.2614.169-3.908
YOY1.6635.337-3.674
5Y2.6356.122-3.487
10Y2.6356.434-3.799
1.3.2. Quick Ratio

Measures if Celularity is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Celularity to the Biotechnology industry mean.
  • A Quick Ratio of 0.08 means the company can pay off $0.08 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Celularity Inc:

  • The MRQ is 0.076. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.113. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.076TTM0.113-0.037
TTM0.113YOY1.126-1.013
TTM0.1135Y2.273-2.159
5Y2.27310Y2.2730.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0763.504-3.428
TTM0.1133.991-3.878
YOY1.1265.371-4.245
5Y2.2736.088-3.815
10Y2.2736.395-4.122

1.4. Solvency of Celularity Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Celularity assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Celularity to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.81 means that Celularity assets are financed with 80.8% credit (debt) and the remaining percentage (100% - 80.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Celularity Inc:

  • The MRQ is 0.808. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.676. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.808TTM0.676+0.131
TTM0.676YOY0.643+0.033
TTM0.6765Y0.533+0.143
5Y0.53310Y0.5330.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8080.339+0.469
TTM0.6760.337+0.339
YOY0.6430.271+0.372
5Y0.5330.368+0.165
10Y0.5330.388+0.145
1.4.2. Debt to Equity Ratio

Measures if Celularity is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Celularity to the Biotechnology industry mean.
  • A Debt to Equity ratio of 419.7% means that company has $4.20 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Celularity Inc:

  • The MRQ is 4.197. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.701. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ4.197TTM2.701+1.496
TTM2.701YOY2.092+0.609
TTM2.7015Y1.690+1.010
5Y1.69010Y1.6900.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1970.392+3.805
TTM2.7010.403+2.298
YOY2.0920.335+1.757
5Y1.6900.427+1.263
10Y1.6900.461+1.229

2. Market Valuation of Celularity Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Celularity generates.

  • Above 15 is considered overpriced but always compare Celularity to the Biotechnology industry mean.
  • A PE ratio of -0.01 means the investor is paying $-0.01 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Celularity Inc:

  • The EOD is -0.178. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.014. Based on the earnings, the company is expensive. -2
  • The TTM is -0.061. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.178MRQ-0.014-0.164
MRQ-0.014TTM-0.061+0.046
TTM-0.061YOY4.144-4.205
TTM-0.0615Y-527.002+526.942
5Y-527.00210Y-527.0020.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.178-2.300+2.122
MRQ-0.014-2.656+2.642
TTM-0.061-2.718+2.657
YOY4.144-4.145+8.289
5Y-527.002-6.258-520.744
10Y-527.002-6.315-520.687
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Celularity Inc:

  • The EOD is -1.955. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.157. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.466. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.955MRQ-0.157-1.798
MRQ-0.157TTM-0.466+0.308
TTM-0.466YOY-3.451+2.985
TTM-0.4665Y-92.625+92.159
5Y-92.62510Y-92.6250.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.955-2.974+1.019
MRQ-0.157-3.306+3.149
TTM-0.466-3.508+3.042
YOY-3.451-5.613+2.162
5Y-92.625-8.378-84.247
10Y-92.625-8.873-83.752
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Celularity is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.18 means the investor is paying $0.18 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Celularity Inc:

  • The EOD is 2.211. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.178. Based on the equity, the company is cheap. +2
  • The TTM is 0.446. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD2.211MRQ0.178+2.033
MRQ0.178TTM0.446-0.268
TTM0.446YOY4.580-4.134
TTM0.4465Y3.234-2.788
5Y3.23410Y3.2340.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.2111.914+0.297
MRQ0.1782.116-1.938
TTM0.4462.097-1.651
YOY4.5802.881+1.699
5Y3.2343.550-0.316
10Y3.2343.936-0.702
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Celularity Inc.

3.1. Institutions holding Celularity Inc

Institutions are holding 14.674% of the shares of Celularity Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Starr International Co., Inc.7.015316.90521528138900
2023-09-30C V Starr & Co Inc3.507730.5931764069300
2023-12-31Vanguard Group Inc1.7138037332062582537.4318
2023-12-31Geode Capital Management, LLC0.449097810600
2023-12-31Renaissance Technologies Corp0.38720.000384347430007455.2216
2023-12-31BlackRock Inc0.3541077141000
2023-12-31Biltmore Family Office, LLC0.1630.0181355000-10000-2.7397
2023-12-31Millennium Management LLC0.14670319633-720951-69.2833
2023-12-31State Street Corporation0.1144024930000
2023-12-31Royal Bank of Canada0.10330225000-4235-1.8474
2023-12-31Ipg Investment Advisors, LLC0.07880.008517169500
2023-12-31Northern Trust Corp0.0635013824800
2023-12-31HB Wealth Management, LLC0.02750.000260000-127500-68
2023-12-31Morgan Stanley - Brokerage Accounts0.0236051306-28859-35.9995
2023-12-31Commonwealth Equity Services Inc0.0187040820500013.9587
2023-12-31Group One Trading, LP0.017703848700
2023-12-31XTX Topco Ltd0.01570.0019341747592.2714
2023-12-31Bank of New York Mellon Corp0.013502930300
2023-12-31Tower Research Capital LLC0.0130.000128341-22393-44.1381
2023-12-31Axxcess Wealth Management, LLC0.01150.000225000-1000-3.8462
Total 14.23847.527631014585-350852-1.1%

3.2. Funds holding Celularity Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv0.10640.000123169000
2023-09-30BlackRock Extended Mkt Composite0.06750.000214702600
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.06140.000513384500
2023-12-31NT Ext Equity Mkt Idx Fd - L0.0350.00037629100
2023-12-31Northern Trust Extended Eq Market Idx0.0350.00037629100
2024-02-29Fidelity Extended Market Index0.02660.000557932-282-0.4844
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.02580.00025624300
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.02070.000245171850.1885
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.0145031525-1593575-98.0601
2023-12-31SSgA U.S. Extended Market Index Class I0.01140.00022490000
2024-02-29Fidelity Total Market Index0.00960.00012101210817106.101
2024-02-29Fidelity Series Total Market Index0.00630.00011365200
2024-03-31BlackRock Extended Equity Market K0.05890.00051283140.0312
2024-02-29Fidelity Nasdaq Composite Index0.0050.000310788-1-0.0093
2023-12-31SSgA U.S. Total Market Index Strategy0.003307182-166-2.2591
2023-12-31Northern Trust Wilshire 50000.00250550400
2023-12-31NT US Market Cap Idx Fd - L0.00250550400
2024-02-29Vanguard Balanced Index Inv0.00250547000
2023-12-31BNYM Mellon SL Market Completion UC10.00190.00024214-67-1.5651
2024-02-29Spartan Extended Market Index Pool E0.00180.000639402807.6503
Total 0.49860.0043971011-1582905-163.0%

3.3. Insider Transactions

Insiders are holding 50.954% of the shares of Celularity Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-12Kok Thay LimBUY21410982.5
2023-10-05Robert J HaririBUY9357581.6
2023-09-29Robert J HaririBUY9064531.7

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Celularity Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.232-1.936+257%2.083-41%0.069+1675%0.069+1675%
Book Value Per Share--1.3893.532-61%2.976-53%4.102-66%4.102-66%
Current Ratio--0.1950.261-25%1.663-88%2.635-93%2.635-93%
Debt To Asset Ratio--0.8080.676+19%0.643+26%0.533+52%0.533+52%
Debt To Equity Ratio--4.1972.701+55%2.092+101%1.690+148%1.690+148%
Dividend Per Share---0.001-100%-0%0.000-100%0.000-100%
Eps---4.310-2.484-42%0.247-1846%-0.407-91%-0.407-91%
Free Cash Flow Per Share---0.393-0.445+13%-0.545+39%-0.277-29%-0.277-29%
Free Cash Flow To Equity Per Share---0.129-0.161+25%-0.317+146%0.528-124%0.528-124%
Gross Profit Margin--1.0001.0000%0.998+0%0.926+8%0.926+8%
Intrinsic Value_10Y_max---24.047--------
Intrinsic Value_10Y_min---20.551--------
Intrinsic Value_1Y_max---1.742--------
Intrinsic Value_1Y_min---1.711--------
Intrinsic Value_3Y_max---5.743--------
Intrinsic Value_3Y_min---5.472--------
Intrinsic Value_5Y_max---10.357--------
Intrinsic Value_5Y_min---9.569--------
Market Cap66873503.000+92%5380376.30018372096.882-71%506523878.973-99%531119617.015-99%531119617.015-99%
Net Profit Margin---24.796-20.545-17%2.288-1184%-6.629-73%-6.629-73%
Operating Margin---4.062-7.143+76%-3.537-13%-4.197+3%-4.197+3%
Operating Ratio--5.3698.509-37%9.528-44%6.261-14%6.261-14%
Pb Ratio2.211+92%0.1780.446-60%4.580-96%3.234-94%3.234-94%
Pe Ratio-0.178-1143%-0.014-0.061+322%4.144-100%-527.002+3677923%-527.002+3677923%
Price Per Share3.070+92%0.2470.406-39%3.928-94%5.560-96%5.560-96%
Price To Free Cash Flow Ratio-1.955-1143%-0.157-0.466+196%-3.451+2093%-92.625+58776%-92.625+58776%
Price To Total Gains Ratio2.491+92%0.200-0.117+158%-11.036+5606%-1852.113+924191%-1852.113+924191%
Quick Ratio--0.0760.113-33%1.126-93%2.273-97%2.273-97%
Return On Assets---0.597-0.391-34%0.010-6303%-0.119-80%-0.119-80%
Return On Equity---3.104-1.756-43%-0.057-98%-0.405-87%-0.405-87%
Total Gains Per Share--1.232-1.935+257%2.083-41%0.070+1670%0.070+1670%
Usd Book Value--30247000.00083655750.000-64%150797750.000-80%130934564.850-77%130934564.850-77%
Usd Book Value Change Per Share--1.232-1.936+257%2.083-41%0.069+1675%0.069+1675%
Usd Book Value Per Share--1.3893.532-61%2.976-53%4.102-66%4.102-66%
Usd Dividend Per Share---0.001-100%-0%0.000-100%0.000-100%
Usd Eps---4.310-2.484-42%0.247-1846%-0.407-91%-0.407-91%
Usd Free Cash Flow---8550000.000-11590500.000+36%-35778000.000+318%-18850741.650+120%-18850741.650+120%
Usd Free Cash Flow Per Share---0.393-0.445+13%-0.545+39%-0.277-29%-0.277-29%
Usd Free Cash Flow To Equity Per Share---0.129-0.161+25%-0.317+146%0.528-124%0.528-124%
Usd Market Cap66873503.000+92%5380376.30018372096.882-71%506523878.973-99%531119617.015-99%531119617.015-99%
Usd Price Per Share3.070+92%0.2470.406-39%3.928-94%5.560-96%5.560-96%
Usd Profit---93876000.000-74929500.000-20%3548000.000-2746%-21831509.000-77%-21831509.000-77%
Usd Revenue--3786000.0003611250.000+5%4493750.000-16%3017700.000+25%3017700.000+25%
Usd Total Gains Per Share--1.232-1.935+257%2.083-41%0.070+1670%0.070+1670%
 EOD+6 -2MRQTTM+15 -20YOY+11 -235Y+12 -2410Y+12 -24

4.2. Fundamental Score

Let's check the fundamental score of Celularity Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.178
Price to Book Ratio (EOD)Between0-12.211
Net Profit Margin (MRQ)Greater than0-24.796
Operating Margin (MRQ)Greater than0-4.062
Quick Ratio (MRQ)Greater than10.076
Current Ratio (MRQ)Greater than10.195
Debt to Asset Ratio (MRQ)Less than10.808
Debt to Equity Ratio (MRQ)Less than14.197
Return on Equity (MRQ)Greater than0.15-3.104
Return on Assets (MRQ)Greater than0.05-0.597
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of Celularity Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.650
Ma 20Greater thanMa 504.298
Ma 50Greater thanMa 1004.647
Ma 100Greater thanMa 2003.710
OpenGreater thanClose3.440
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets157,192
Total Liabilities126,945
Total Stockholder Equity30,247
 As reported
Total Liabilities 126,945
Total Stockholder Equity+ 30,247
Total Assets = 157,192

Assets

Total Assets157,192
Total Current Assets16,498
Long-term Assets140,694
Total Current Assets
Cash And Cash Equivalents 273
Net Receivables 6,186
Inventory 4,934
Other Current Assets 5,105
Total Current Assets  (as reported)16,498
Total Current Assets  (calculated)16,498
+/-0
Long-term Assets
Property Plant Equipment 81,686
Goodwill 7,347
Intangible Assets 11,554
Long-term Assets Other 40,107
Long-term Assets  (as reported)140,694
Long-term Assets  (calculated)140,694
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities84,632
Long-term Liabilities42,313
Total Stockholder Equity30,247
Total Current Liabilities
Short-term Debt 35,004
Accounts payable 12,931
Other Current Liabilities 34,239
Total Current Liabilities  (as reported)84,632
Total Current Liabilities  (calculated)82,174
+/- 2,458
Long-term Liabilities
Long-term Liabilities  (as reported)42,313
Long-term Liabilities  (calculated)0
+/- 42,313
Total Stockholder Equity
Common Stock19
Retained Earnings -851,338
Accumulated Other Comprehensive Income 2,395
Other Stockholders Equity 879,171
Total Stockholder Equity (as reported)30,247
Total Stockholder Equity (calculated)30,247
+/-0
Other
Cash and Short Term Investments 273
Common Stock Shares Outstanding 18,832
Current Deferred Revenue2,458
Liabilities and Stockholders Equity 157,192
Net Debt 60,805
Net Working Capital -68,134
Short Long Term Debt Total 61,078



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
186
289,723
290,765
291,605
292,620
292,410
292,365
431,008
291,928
128,415
448,286
414,128
434,202
429,337
437,116
401,066
362,416
246,419
157,192
157,192
157,192157,192246,419362,416401,066437,116429,337434,202414,128448,286128,415291,928431,008292,365292,410292,620291,605290,765289,723186
   > Total Current Assets 
19
1,304
1,260
1,009
624
815
520
72,160
100
58
91,281
37,240
75,739
75,453
63,097
33,502
25,004
18,037
16,498
16,498
16,49816,49818,03725,00433,50263,09775,45375,73937,24091,2815810072,1605208156241,0091,2601,30419
       Cash And Cash Equivalents 
19
1,169
1,025
917
505
717
454
54,311
29
0
72,716
37,240
48,039
37,996
42,649
13,966
8,532
3,084
273
273
2732733,0848,53213,96642,64937,99648,03937,24072,71602954,3114547175059171,0251,16919
       Net Receivables 
0
0
0
0
0
0
0
6,550
6,472
2,995
3,684
5,233
6,014
6,633
8,372
6,966
5,165
4,884
4,114
6,186
6,1864,1144,8845,1656,9668,3726,6336,0145,2333,6842,9956,4726,5500000000
       Other Current Assets 
0
135
236
92
119
98
66
873
71
58
1
2
2
6,161
6,837
9,776
7,938
4,331
5,105
5,105
5,1055,1054,3317,9389,7766,8376,16122158718736698119922361350
   > Long-term Assets 
167
288,419
289,505
290,596
291,996
291,595
291,845
358,848
291,828
128,358
357,005
376,888
358,463
353,884
374,019
367,564
337,412
228,382
140,694
140,694
140,694140,694228,382337,412367,564374,019353,884358,463376,888357,005128,358291,828358,848291,845291,595291,996290,596289,505288,419167
       Property Plant Equipment 
0
0
0
0
0
0
0
90,077
90,447
90,337
91,007
90,625
93,653
90,567
90,074
88,715
87,135
85,724
81,686
81,686
81,68681,68685,72487,13588,71590,07490,56793,65390,62591,00790,33790,44790,0770000000
       Goodwill 
0
0
0
0
0
0
0
123,304
0
0
123,304
123,304
123,304
123,304
123,304
119,694
90,061
90,061
7,347
7,347
7,3477,34790,06190,061119,694123,304123,304123,304123,304123,30400123,3040000000
       Intangible Assets 
0
0
0
0
0
0
0
125,379
0
0
123,739
123,187
122,646
122,100
121,547
120,994
120,453
12,107
11,554
11,554
11,55411,55412,107120,453120,994121,547122,100122,646123,187123,73900125,3790000000
       Long-term Assets Other 
167
288,419
-495
-405
-4
-414
291,845
20,088
291,785
128,358
18,955
39,772
18,860
3,074
24,252
38,161
24,929
40,490
40,107
40,107
40,10740,10740,49024,92938,16124,2523,07418,86039,77218,955128,358291,78520,088291,845-414-4-405-495288,419167
> Total Liabilities 
162
11,037
10,959
11,042
11,031
10,965
10,958
962,408
39,765
47,455
352,070
314,710
344,297
279,187
272,881
202,165
206,788
127,918
126,945
126,945
126,945126,945127,918206,788202,165272,881279,187344,297314,710352,07047,45539,765962,40810,95810,96511,03111,04210,95911,037162
   > Total Current Liabilities 
162
173
107
229
129
153
141
26,677
5,160
7,292
29,212
26,225
26,034
32,939
69,219
62,088
66,458
64,976
84,632
84,632
84,63284,63264,97666,45862,08869,21932,93926,03426,22529,2127,2925,16026,677141153129229107173162
       Short-term Debt 
0
0
0
0
0
0
0
3,008
0
1,109
3,046
3,051
0
0
39,255
37,603
30,945
16,816
0
35,004
35,004016,81630,94537,60339,255003,0513,0461,10903,0080000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
1,109
0
0
0
0
39,255
37,603
30,945
16,816
35,004
0
035,00416,81630,94537,60339,25500001,109000000000
       Accounts payable 
0
56
107
210
67
48
60
5,390
5,040
7,292
7,031
9,317
10,418
10,226
9,216
5,810
8,755
12,448
12,931
12,931
12,93112,93112,4488,7555,8109,21610,22610,4189,3177,0317,2925,0405,390604867210107560
       Other Current Liabilities 
162
117
107
19
62
104
82
13,451
120
6,183
17,102
11,661
13,438
20,482
18,507
16,402
24,559
33,401
0
34,239
34,239033,40124,55916,40218,50720,48213,43811,66117,1026,18312013,451821046219107117162
   > Long-term Liabilities 
0
10,864
10,852
10,813
10,903
10,813
10,816
935,731
34,605
40,163
322,858
288,485
318,263
246,248
203,662
140,077
140,330
62,942
42,313
42,313
42,31342,31362,942140,330140,077203,662246,248318,263288,485322,85840,16334,605935,73110,81610,81310,90310,81310,85210,8640
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,745
0
0
0
0004,7450000000000000000
       Warrants
0
273,685
274,806
275,564
276,588
276,445
276,407
0
291,745
128,365
0
0
0
0
0
0
0
0
0
0
0000000000128,365291,7450276,407276,445276,588275,564274,806273,6850
       Other Liabilities 
0
0
0
0
0
0
0
357,984
414,309
424,801
294,836
260,400
287,800
218,398
175,745
0
0
17,813
0
0
0017,81300175,745218,398287,800260,400294,836424,801414,309357,9840000000
       Deferred Long Term Liability 
0
52
39
0
90
0
4
0
23,793
29,350
7
0
10
10
10
0
9
0
0
0
000901010100729,35023,79304090039520
> Total Stockholder Equity
24
278,685
279,806
280,564
281,588
281,445
281,407
-531,400
252,162
80,961
96,216
99,418
89,905
150,150
164,235
198,901
155,628
118,501
30,247
30,247
30,24730,247118,501155,628198,901164,235150,15089,90599,41896,21680,961252,162-531,400281,407281,445281,588280,564279,806278,68524
   Common Stock
1
273,686
274,807
275,565
276,589
276,446
276,408
1
291,746
128,366
10
12
14
14
14
15
17
18
0
19
1901817151414141210128,366291,7461276,408276,446276,589275,565274,807273,6861
   Retained Earnings 
-1
633
1,755
2,512
3,537
3,393
3,355
-563,563
-39,584
-47,405
-659,641
-663,681
-722,552
-674,729
-669,930
-645,496
-709,513
-757,462
-851,338
-851,338
-851,338-851,338-757,462-709,513-645,496-669,930-674,729-722,552-663,681-659,641-47,405-39,584-563,5633,3553,3933,5372,5121,755633-1
   Capital Surplus 
0
4,366
3,245
2,487
1,463
1,606
1,644
0
48,381
0
755,847
0
812,443
824,865
833,915
0
862,457
0
0
0
000862,4570833,915824,865812,4430755,847048,38101,6441,6061,4632,4873,2454,3660
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
24
4,366
3,245
2,487
1,463
1,606
1,644
32,162
5,118
1
755,847
763,087
812,443
395,528
396,799
844,373
862,457
873,557
0
879,171
879,1710873,557862,457844,373396,799395,528812,443763,087755,84715,11832,1621,6441,6061,4632,4873,2454,36624



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue14,788
Cost of Revenue-11,654
Gross Profit3,1343,134
 
Operating Income (+$)
Gross Profit3,134
Operating Expense-136,323
Operating Income-121,535-133,189
 
Operating Expense (+$)
Research Development41,727
Selling General Administrative56,588
Selling And Marketing Expenses-
Operating Expense136,32398,315
 
Net Interest Income (+$)
Interest Income415
Interest Expense-2,352
Other Finance Cost-0
Net Interest Income-1,937
 
Pretax Income (+$)
Operating Income-121,535
Net Interest Income-1,937
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-181,395-63,612
EBIT - interestExpense = -2,352
-181,408
-179,056
Interest Expense2,352
Earnings Before Interest and Taxes (EBIT)--179,043
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-181,395
Tax Provision-13
Net Income From Continuing Ops-181,408-181,408
Net Income-181,408
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-57,9231,937
 

Technical Analysis of Celularity
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Celularity. The general trend of Celularity is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Celularity's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Celularity Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 3.5 < 4.7 < 4.7.

The bearish price targets are: 1.87 > 1.69.

Tweet this
Celularity Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Celularity Inc. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Celularity Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Celularity Inc. The current macd is -0.51288751.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Celularity price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Celularity. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Celularity price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Celularity Inc Daily Moving Average Convergence/Divergence (MACD) ChartCelularity Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Celularity Inc. The current adx is 26.46.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Celularity shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Celularity Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Celularity Inc. The current sar is 4.38304956.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Celularity Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Celularity Inc. The current rsi is 32.65. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Celularity Inc Daily Relative Strength Index (RSI) ChartCelularity Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Celularity Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Celularity price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Celularity Inc Daily Stochastic Oscillator ChartCelularity Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Celularity Inc. The current cci is -84.61701471.

Celularity Inc Daily Commodity Channel Index (CCI) ChartCelularity Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Celularity Inc. The current cmo is -43.99641911.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Celularity Inc Daily Chande Momentum Oscillator (CMO) ChartCelularity Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Celularity Inc. The current willr is -97.03703704.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Celularity Inc Daily Williams %R ChartCelularity Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Celularity Inc.

Celularity Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Celularity Inc. The current atr is 0.46427847.

Celularity Inc Daily Average True Range (ATR) ChartCelularity Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Celularity Inc. The current obv is 8,495,239.

Celularity Inc Daily On-Balance Volume (OBV) ChartCelularity Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Celularity Inc. The current mfi is 11.97.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Celularity Inc Daily Money Flow Index (MFI) ChartCelularity Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Celularity Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Celularity Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Celularity Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.650
Ma 20Greater thanMa 504.298
Ma 50Greater thanMa 1004.647
Ma 100Greater thanMa 2003.710
OpenGreater thanClose3.440
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Celularity with someone you think should read this too:
  • Are you bullish or bearish on Celularity? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Celularity? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Celularity Inc

I send you an email if I find something interesting about Celularity Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Celularity Inc.

Receive notifications about Celularity Inc in your mailbox!